D93902
Diethylenetriaminepentaacetic acid
97%
Synonym(s):
(Carboxymethylimino)bis(ethylenenitrilo)tetraacetic acid, N,N-Bis(2-[bis(carboxymethyl)amino]ethyl)glycine, DETAPAC, DTPA, Penta(carboxymethyl)diethylenetriamine, Pentetic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
[(HOOCCH2)2NCH2CH2]2NCH2COOH
CAS Number:
Molecular Weight:
393.35
EC Number:
200-652-8
UNSPSC Code:
12352200
MDL number:
Beilstein/REAXYS Number:
1810219
assay
97%
mp
219-220 °C (lit.)
SMILES string
OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O
InChI
1S/C14H23N3O10/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27)
InChI key
QPCDCPDFJACHGM-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Diethylenetriaminepentaacetic acid
Storage Class
11 - Combustible Solids
flash_point_f
392.0 °F - closed cup
flash_point_c
200 °C - closed cup
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nikki Rink et al.
Pediatric nephrology (Berlin, Germany), 30(8), 1327-1336 (2015-04-10)
The current glomerular filtration rate (GFR) equation (CKiD) may be less accurate in adolescents and children with higher GFR. This was a retrospective study (n = 161, 247 (99)mTc DTPA-GFRs). Six equations were evaluated for bias, accuracy, and low GFR diagnosis: (1)
Janice S C Chew-Harris et al.
Annals of clinical biochemistry, 50(Pt 1), 39-46 (2012-11-07)
It is well known that plasma creatinine concentration is affected by muscle mass, while some studies have suggested cystatin C is affected by body mass index (BMI). Our aim was to assess the effects of lean versus fat mass on
Carolyn Y Ho et al.
JACC. Heart failure, 3(2), 180-188 (2014-12-30)
The study sought to assess the safety, feasibility, and effect of diltiazem as disease-modifying therapy for at-risk hypertrophic cardiomyopathy (HCM) mutation carriers. HCM is caused by sarcomere mutations and characterized by left ventricular hypertrophy (LVH) with increased risk of heart failure